1
/
of
1
Elabscience
SKU:E-CL-H1263
Human tPA(Tissue-type Plasminogen Activator) CLIA Kit
Human tPA(Tissue-type Plasminogen Activator) CLIA Kit
Regular price
$682.00 USD
Regular price
Sale price
$682.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Human tPA (Tissue-type Plasminogen Activator) CLIA Kit, a cutting-edge diagnostic tool designed to accurately measure the levels of tPA in human samples. This advanced kit utilizes the Chemiluminescent Immunoassay (CLIA) technique, ensuring precise and reliable results for clinical and research applications.
The Human tPA CLIA Kit is meticulously crafted with utmost attention to detail, employing state-of-the-art technology and high-quality materials. It offers a comprehensive solution for the quantitative determination of tPA, a crucial enzyme involved in the fibrinolytic system, which plays a pivotal role in maintaining hemostasis.
With its user-friendly design, this CLIA Kit enables seamless and efficient operation, making it suitable for both experienced laboratory professionals and novices alike. The kit includes all necessary components, including pre-coated microplates, tPA standards, controls, and detection reagents, ensuring convenience and ease of use.
The Human tPA CLIA Kit boasts exceptional sensitivity and specificity, allowing for accurate detection and quantification of tPA levels within a wide dynamic range. Its robust performance guarantees reliable and reproducible results, facilitating precise monitoring of tPA levels in various biological samples.
This innovative diagnostic tool holds immense potential in clinical settings, aiding in the diagnosis and management of thrombotic disorders, cardiovascular diseases, and other conditions associated with abnormal tPA levels. Furthermore, it serves as an invaluable asset in research laboratories, facilitating in-depth investigations into the role of tPA in various physiological and pathological processes.
In summary, the Human tPA CLIA Kit represents a breakthrough in diagnostic technology, offering unparalleled accuracy, reliability, and convenience. With its exceptional performance and comprehensive features, this kit is poised to revolutionize the field of tPA analysis, empowering researchers and clinicians alike to unravel the complexities of tPA-related disorders and pave the way for improved patient care.
The Human tPA CLIA Kit is meticulously crafted with utmost attention to detail, employing state-of-the-art technology and high-quality materials. It offers a comprehensive solution for the quantitative determination of tPA, a crucial enzyme involved in the fibrinolytic system, which plays a pivotal role in maintaining hemostasis.
With its user-friendly design, this CLIA Kit enables seamless and efficient operation, making it suitable for both experienced laboratory professionals and novices alike. The kit includes all necessary components, including pre-coated microplates, tPA standards, controls, and detection reagents, ensuring convenience and ease of use.
The Human tPA CLIA Kit boasts exceptional sensitivity and specificity, allowing for accurate detection and quantification of tPA levels within a wide dynamic range. Its robust performance guarantees reliable and reproducible results, facilitating precise monitoring of tPA levels in various biological samples.
This innovative diagnostic tool holds immense potential in clinical settings, aiding in the diagnosis and management of thrombotic disorders, cardiovascular diseases, and other conditions associated with abnormal tPA levels. Furthermore, it serves as an invaluable asset in research laboratories, facilitating in-depth investigations into the role of tPA in various physiological and pathological processes.
In summary, the Human tPA CLIA Kit represents a breakthrough in diagnostic technology, offering unparalleled accuracy, reliability, and convenience. With its exceptional performance and comprehensive features, this kit is poised to revolutionize the field of tPA analysis, empowering researchers and clinicians alike to unravel the complexities of tPA-related disorders and pave the way for improved patient care.
Share
